Xilio Therapeutics, Inc.

NASDAQ:XLO

0.7559 (USD) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 55.29161.25974.94933.9844.70459.77275.38393.271120.385139.143159.41176.959198.05399.767120.299141.22219.238-48.845
Short Term Investments 0000000000000000097.69
Cash and Short Term Investments 55.29161.25974.94933.9844.70459.77275.38393.271120.385139.143159.41176.959198.05399.767120.299141.22219.23848.845
Net Receivables 0003000000000000000
Inventory 000000000000000000
Other Current Assets 4.9432.053.0595.2053.4234.7083.0427.418.2226.3427.1948.2568.9285.8054.2871.41.3520
Total Current Assets 60.23463.30978.00869.18548.12764.4878.42593.271124.496142.314163.007181.087202.517105.572124.586142.62220.5948.845
Non-Current Assets:
Property, Plant & Equipment, Net 9.0599.57410.00410.5411.20111.61312.16312.72912.8413.24213.23113.35313.59713.17313.44913.69913.6760
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 000000000000-5.09200000
Long Term Investments 001.7692.7631.5871.581.5741.5681.5621.5571.5541.5531.5531.5531.5531.55300
Tax Assets 0000000000003.53900000
Other Non-Current Assets 1.7821.7750.0920.1210.0110.1690.1973.9370.2670.3010.3350.359-3.1460.4270.4360.472.051-48.845
Total Non-Current Assets 10.84111.34911.86513.42412.79913.36213.93418.23414.66915.115.1215.26515.54315.15315.43815.72215.727-48.845
Total Assets 71.07574.65889.87382.60960.92677.84292.359111.505139.165157.414178.127196.352218.06120.725140.024158.34436.3170
Liabilities & Equity:
Current Liabilities:
Account Payables 2.5740.9721.2640.7461.051.4860.9452.0133.1251.811.412.3243.1443.8228.4092.6085.4440
Short Term Debt 1.1881.1522.2321.0811.0472.0281.9627.6167.5856.7765.0493.3250.8011.5464.7464.0522.8970
Tax Payables 000000000000000000
Deferred Revenue 13.51826.10526.51721.72509.4047.1400012.08708.7518.1948.068013.7320
Other Current Liabilities 9.9819.7938.6288.0313.8613.41513.3866.56510.4098.25611.3116.5768.8337.5038.159.63413.8140
Total Current Liabilities 27.26138.02238.64131.58215.95716.92916.29316.19421.11916.84217.7712.22512.77812.87121.30516.29422.1550
Non-Current Liabilities:
Long Term Debt 6.9547.2637.5667.86316.28416.838.68210.49312.35414.2116.05817.90619.73530.21216.00317.17118.320
Deferred Revenue Non-Current 19.2628.39910.2517.39900000000-3.53900000
Deferred Tax Liabilities Non-Current 000-17.399000000003.53900000
Other Non-Current Liabilities 0000-8.142-8.4150.0070.0260.0450.0640.0820.10.118214.097224.0251.12679.1290
Total Non-Current Liabilities 26.21615.66217.81625.2628.1428.4158.68910.51912.39914.27416.1418.00619.853244.309240.02818.29797.4490
Total Liabilities 53.47753.68456.45756.84424.09925.34424.98226.71333.51831.11633.9130.23132.631257.18261.33334.591119.6040
Equity:
Preferred Stock 0000000000000222.888222.888222.88878.00268.033
Common Stock 0.0050.0040.0040.0030.0030.0030.0030.0030.0030.0030.0030.0030.00300.0010.00100
Retained Earnings -383.753-370.66-356.64-342.715-325.512-307.857-291.109-271.754-249.108-226.642-206.852-182.239-160.886-141.185-124.934-101.753-85.0860
Accumulated Other Comprehensive Income/Loss 000000-00000000-222.889-0-0-29.523
Other Total Stockholders Equity 401.346391.63390.052368.477362.336360.352358.483356.543354.752352.937351.066348.357346.3124.73-219.2632.617-76.2030
Total Shareholders Equity 17.59820.97433.41625.76536.82752.49867.37784.792105.647126.298144.217166.121185.429-136.455-121.309123.753-83.28738.51
Total Equity 17.59820.97433.41625.76536.82752.49867.37784.792105.647126.298144.217166.121185.429-136.455-121.309123.753-83.28738.51
Total Liabilities & Shareholders Equity 71.07574.65889.87382.60960.92677.84292.359111.505139.165157.414178.127196.352218.06120.725140.024158.34436.31738.51